Navigation Links
Pioneer(R) Surgical Technology, Inc. Closes $15 Million Series B Financing
Date:12/16/2008

MARQUETTE, Mich., Dec. 16 /PRNewswire/ -- Pioneer Surgical Technology, Inc., a leading innovator in the design and manufacture of spinal and orthopedic implants and instruments, today announced the closing of Series B financing totaling $15 million. Pioneer attracted new participation from InvestMichigan! Growth Capital Fund (IMGCF). Previous investors Pharos Capital Group, LLC; Highlander Partners, LP; Hopewell Ventures; and River Cities Capital Funds also participated in the round.

Pioneer's CEO and Chairman of the Board, Matthew N. Songer, MD, MBA says, "This capital will fund our FDA pivotal study for the NuBac nucleus replacement device, enabling us to bring this innovative P3(TM) technology to the U.S. market."

Pioneer is the first and only company to receive FDA approval to start the IDE pivotal study for lumbar nucleus replacement. The NuBac is a minimally-invasive device and is the first in a family of PEEK-on-PEEK articulating discs and implants developed by Pioneer.

IMGCF co-manager Charles Rothstein, of Beringea, Inc., commented, "With its focus on one of the largest, fastest growing and most profitable segments in the medical device industry, we feel confident Pioneer Surgical will be a valuable addition to the IMGCF portfolio."

The NuBac implant system is the only Nucleus Replacement device that utilizes an articulating inner ball and socket design that seeks to achieve load sharing and uniform stress distribution under various physiological loading conditions while minimizing extrusion risk. The NuBac implant is made of PEEK-OPTIMA(R) material which offers well established biocompatibility, biodurability, excellent wear resistance, and radiolucency.

San Francisco, California-based Thomas Weisel Partners served as sole financial advisor to Pioneer in connection with the Series B financing.

About Pioneer Surgical Technology

Pioneer Surgi
'/>"/>

SOURCE Pioneer Surgical Technology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Pioneer(R) Surgical Technologys NuBac(R) Nucleus Replacement Device Wins FDA Approval for IDE Pivotal Study
2. Pioneer(R) Surgical Technology Announces the Market Release of its Cross-Fuse(TM) Lateral Vertebral Body Replacement (VBR) System
3. Pioneer(R) Surgical Technology Introduces the BacJac(TM) Interspinous Decompression System to the European Spine Market
4. Pioneer(R) Surgical Technology, Inc. Continues to Prove Science Behind PEEK-on-PEEK(TM) Technology for Motion Preservation Devices
5. Aurora and Associated Surgical & Medical Specialists Announce Surgery Center Joint Venture
6. American College of Surgeons Issues New Health Care Reform Agenda, Emphasizes Need to Address Access, Surgical Workforce Shortage
7. Intelligent materials to revolutionize surgical implants
8. Levaquin is the Preferred Quinolone Among More Than Half of All General Medical-Surgical Hospitals in the United States
9. Molecular Breast Imaging Proves Cost-Effective for Presurgical Planning in Patients with Breast Cancer
10. Cardinal Health, SRI Surgical Sign Five-Year Agreement For Surgical Kits
11. New Surgical Approach Shows Promise in Treatment of Scoliosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Because heart cells cannot multiply and cardiac muscles ... to repair itself after a heart attack. Now ... new gold standard in cardiac tissue engineering. , ... Shevach of TAU,s Department of Biotechnology, Department of ... and Nanotechnology, have been developing sophisticated micro- and ...
(Date:9/30/2014)... Dublin, Ireland, September 30th, 2014 A new ... to TILDA (The Irish Longitudinal Study on Ageing) ... and Midwifery, Trinity College Dublin, Ireland, has highlighted ... challenges facing Ireland,s intellectual disability population. , The ... kind in Europe and the only one in ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 MyServer2Go.com ... Arvixe as the Best VPS Hosting this year for ... well as affordable price. , MyServer2Go.com is a ... of VPS hosting services. And this announcement will help ... , According to MyServer2Go.com, Arvixe ( http://www.arvixe.com ) is ...
(Date:9/30/2014)... September 30, 2014 The accurate ... improve breast cancer risk prediction and to tailor ... study published in Breast Cancer Research (BCR September ... and breast cancer risk: a case-control study of ... connection between breast density and breast cancer risk. ...
(Date:9/30/2014)... choice to die at home surrounded by loved ones ... happens and how to change the process so that ... focus of new research the Frances Payne Bolton School ... with a four-year, $2.06 million grant from the National ... "Mapping Complex Influences of Aggressiveness of End of Life ...
Breaking Medicine News(10 mins):Health News:A heartbeat away? Hybrid 'patch' could replace transplants 2Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 2Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 3Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 4Health News:Arvixe Is Named Best VPS Hosting by MyServer2Go.com 2Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 2Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 3Health News:Mammographic Density Offers Potential to Improve Prediction of Breast Cancer Risk and Development of Personalized Screening 4Health News:CWRU researchers receives $2.06 million to study how patients make end-of-life decisions 2
... As the general election,campaign begins in earnest today, ... is looking to the two presidential,candidates for a ... Now that the Democratic and Republican conventions are ... the significant obstacles faced,by small businesses as they ...
... disease resistance to anti-hormonal therapy , , FRIDAY, Sept. ... help "re-sensitize" certain breast cancer tumors to anti-hormonal ... , Women with estrogen-receptor or progesterone-receptor positive (ER ... anti-hormonal medicines, such as aromatase inhibitors, to keep ...
... hormone-receptor positive, metastatic breast cancer may take medications for ... when the tumor becomes resistant to anti-hormonal drugs, treatment ... presented today at the 2008 ASCO Breast Cancer Symposiummay ... treatment approach can "re-sensitize" the tumor, allowing anti-hormonal drugs ...
... to Feature VelaShape. , ... New York, New York ... Centers __title__ American Laser], the largest provider of laser hair removal ... the STYLE360 show during New York Fashion Week. STYLE360, from ...
... Free drug samples provided to physicians by pharmaceutical companies ... long run, according to a study done by researchers ... , The retrospective study looked at the prescribing habits ... medicine practice in the months immediately before and after ...
... September 3, 2008In a case-control study, the presence of ... with autism and GI disturbances than in children with ... onset were unrelated to MMR vaccine timing. Study ... of Science on September 4 ( http://dx.plos.org/10.1371/journal.pone.0003140 ). ...
Cached Medicine News:Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 2Health News:Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns 3Health News:Drug Re-Sensitizes Breast Tumors to Treatment 2Health News:1 step back ... 2 steps forward 2Health News:American Laser Centers Sponsors STYLE360 to Share the Skinny on Body Shaping 2Health News:Free drug samples may end up costing uninsured more 2Health News:Free drug samples may end up costing uninsured more 3Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 2Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 3
(Date:9/30/2014)... 30, 2014  Come fall, many children, teenagers, and ... they want to be for Halloween. And, a number ... decorative contact lenses bought without a prescription. ... people purchase and wear contact lenses without a prescription. ... ® consumer survey, 17 percent of Americans have ...
(Date:9/30/2014)... Established and new medical technology service ... penetrate the growing Eastern European medical devices market. ... team and regional/local offices, reducing the costs incurred ... crucial advantage as medical technology service providers are ... New analysis from Frost & Sullivan, Medical Technologies ...
(Date:9/30/2014)... , September 30, 2014 ... diagnostic reagents is undergoing earthshaking changes. The country,s new ... administration of in-vitro diagnostic reagents are far from perfect ... the past 30 years. Chinese state council issued the ... Devices" on February 12, 2014, and it has come ...
Breaking Medicine Technology:The Spooky Truth: What You Need To Know About Contact Lens Hygiene 2The Spooky Truth: What You Need To Know About Contact Lens Hygiene 3Global Medical Manufacturers Turn to Distributors to Tap the Eastern European Market 2Global Medical Manufacturers Turn to Distributors to Tap the Eastern European Market 3Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition) 5
... , NEW YORK, Nov. 24 ... Ron Bentsur, the Company,s Chief Executive Officer, is scheduled to ... being held in New York City. , Mr. Bentsur,s presentation ... ET and will be accessible from the Investor Information page ...
... HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA) an online U.S. ... quarter ended September 30, 2009. The company reported quarterly revenue ... pharmacy transfers. Gross margins increased 13.0% year-over-year to 34.6% and ... a net loss of $186,299 for the three months ended ...
Cached Medicine Technology:Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 2HealthWarehouse.com, Inc. Announces Third Quarter Financial Results; Revenues, Margins, and Orders Shipped Increase Over Third Quarter 2008 3
Used for the retrieval of stones, stents, or other objects in the urinary tract under direct vision. Retrieval Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in p...
... technology allows the grasper ... a shorter length and ... the stone. The Unidex ... one-handed operation. Supplied sterile ...
Bugbee Fulgurating...
Fulgurating Electrode, 2 F...
Medicine Products: